Ligand validation:6LYK

GLN: GLUTAMINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LYK_GLN_A_1618	76%	55%	0.11	0.947	0.64	1.07	-	1	2	0	100%	0.96
6JTA_GLN_A_1302	62%	44%	0.123	0.914	1.35	0.82	1	-	4	0	100%	0.94
3H0M_GLN_V_908	99%	44%	0.038	0.994	1.24	0.95	1	-	13	0	90%	0.9
4ZFK_GLN_A_305	98%	48%	0.06	0.986	0.73	1.25	-	2	1	0	100%	1
8B5D_GLN_B_404	95%	51%	0.065	0.969	1.12	0.8	1	-	3	0	100%	1
4ZV2_GLN_A_301	93%	43%	0.083	0.977	0.85	1.36	1	2	0	0	100%	1
2NV2_GLN_P_6032	91%	45%	0.075	0.963	1	1.11	1	2	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.